Fexofenadine Related Published Studies
Well-designed clinical trials related to Fexofenadine
Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine
on psychomotor function and histamine-induced wheal- and flare-responses: a
randomized double-blind, placebo-controlled study in healthy volunteers. [2012]
Intranasal phototherapy is more effective than fexofenadine hydrochloride in the treatment of seasonal allergic rhinitis: results of a pilot study. [2011.03]
The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. [2011.02]
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. [2011]
Effect of metronidazole on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy male volunteers. [2010.07]
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. [2010.05]
Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS. [2010.04]
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on
allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in
the Vienna Challenge Chamber. [2010]
Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis. [2009.12]
Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics. [2009.12]
Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers. [2009.06]
Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil. [2009.05]
Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. [2009.03]
Bioequivalence of fexofenadine tablet formulations assessed in healthy Iranian volunteers. [2009]
Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit. [2009]
Fexofenadine effects on cognitive performance in aviators at ground level and simulated altitude. [2008.08]
Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis. [2007.12]
Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old. [2007.10]
The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. [2007.02]
Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare. [2007.01]
Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine. [2006.11]
[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial] [2006.11]
[Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial] [2006.11]
Time-dependent interaction between lopinavir/ritonavir and fexofenadine. [2006.07]
A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance. [2006.07]
Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis. [2006.05]
Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. [2006.05]
Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis. [2006.04]
Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. [2006.02]
Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis. [2006.02]
Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. [2005.10]
Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. [2005.09]
Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers. [2005.09]
Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism. [2005.08]
Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit. [2005.07]
Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. [2005.07]
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. [2005.06]
Comparative effects of fexofenadine and montelukast on allergen-induced wheal and flare. [2005.05]
Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults. [2005.05]
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. [2005.03]
Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. [2005.02]
Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. [2005.01]
Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination. [2005.01]
Well-designed clinical trials possibly related to Fexofenadine
Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small,
randomized, double-blind, placebo-controlled, counterbalanced, crossover trial
assessing daily pain levels. [2013]
Long-term effects of doxazosin, finasteride, and combination therapy on quality
of life in men with benign prostatic hyperplasia. [2013]
Targeted anti-inflammatory systemic therapy for restenosis: The Biorest Liposomal
Alendronate with Stenting sTudy (BLAST)-a double blind, randomized clinical
trial. [2013]
A Multicentre Randomised Trial of Atorvastatin Therapy in Intensive Care Patients
with Severe Sepsis. [2013]
Sodium hyaluronate for the treatment of chronic shoulder pain associated with
glenohumeral osteoarthritis: a multicenter, randomized, double-blind,
placebo-controlled trial. [2013]
Effect of dietary myo-inositol supplementation in pregnancy on the incidence of
maternal gestational diabetes mellitus and fetal outcomes: a randomized
controlled trial. [2013]
Effect of vitamin D supplementation on progression of knee pain and cartilage
volume loss in patients with symptomatic osteoarthritis: a randomized controlled
trial. [2013]
Effect of valsartan on systemic right ventricular function: a double-blind,
randomized, placebo-controlled pilot trial. [2013]
Assessment of cognitive impairments and seizure characteristics in
electroconvulsive therapy with and without sodium valproate in manic patients. [2013]
Zinc and copper supplementation are not cost-effective interventions in the
treatment of acute diarrhea. [2013]
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D
conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster
randomised trial. [2013]
Efficacy and safety of everolimus for subependymal giant cell astrocytomas
associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised,
placebo-controlled phase 3 trial. [2013]
Randomized clinical trial of goal-directed fluid therapy within an enhanced
recovery protocol for elective colectomy. [2013]
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter
double-blind, randomized controlled trial. [2013]
Periarticular infiltration of 0.25% bupivacaine on top of femoral nerve block and
intrathecal morphine improves quality of pain control after total knee
arthroplasty: a randomized double-blind placebo controlled clinical trial. [2012]
Hyperbaric side effects in a traumatic brain injury randomized clinical trial. [2012]
Efficacy and tolerability of a cream containing AR-GG27® (sorbityl furfural
palmitate) in the treatment of mild/moderate childhood atopic dermatitis
associated with pityriasis alba. A double-blind, placebo-controlled clinical
trial. [2012]
Randomized, double-blind, parallel-controlled clinical trial on correspondence of
prescriptions and traditional Chinese medicine syndrome of ischemic stroke. [2012]
[Meta-analysis of Dengzhanxixin injection treatment for unstable angina
pectoris]. [Article in Chinese] [2012]
Phase II trial of methotrexate in myasthenia gravis. [2012]
Repurposing of yunnan baiyao as an alternative therapy for minor recurrent
aphthous stomatitis. [2012]
Psychogenic nonepileptic seizures: a treatment review. What have we learned since
the beginning of the millennium? [2012]
Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With
Type 2 Diabetes and Coronary Artery Disease. [2012]
Randomized controlled trial of interventions for young people at ultra-high risk
of psychosis: twelve-month outcome. [2012]
Current position of phenobarbital in epilepsy and its future. [2012]
The DRD4 Exon III VNTR, Bupropion, and Associations With Prospective Abstinence. [2012]
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results
of two randomized, double-blind, parallel-sequential trials. [2012]
Assessment of the effects of a stannous fluoride dentifrice on gingivitis in a
two-month positive-controlled clinical study. [2012]
The effect of zinc acetate and magnolia bark extract added to chewing gum on
volatile sulfur-containing compounds in the oral cavity. [2012]
Effects of continuous positive airway pressure on neurocognitive function in
obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy
Study (APPLES). [2012]
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial
of suvorexant. [2012]
Pilot study comparing total intravenous anesthesia to inhalational anesthesia in
endoscopic sinus surgery: novel approach of blood flow quantification. [2012]
Comprehensive self management and routine monitoring in chronic obstructive
pulmonary disease patients in general practice: randomised controlled trial. [2012]
The effect of an osmotic contrast agent on complete meconium evacuation in
preterm infants. [2012]
Adsorptive granulocyte/monocyte apheresis for the maintenance of remission in
patients with ulcerative colitis: a prospective randomized, double blind,
sham-controlled clinical trial. [2012]
Autologous olfactory mucosal cell transplants in clinical spinal cord injury: a
randomized double-blinded trial in a canine translational model. [2012]
Effect of citicoline on functional and cognitive status among patients with
traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). [2012]
Oral L-arginine supplementation in patients with mild arterial hypertension and
its effect on plasma level of asymmetric dimethylarginine, L-citruline,
L-arginine and antioxidant status. [2012]
Is low level laser effective for the treatment of orofacial pain?: A systematic
review. [2012]
Effect of gabapentin on postoperative pain and operation complications: a
randomized placebo controlled trial. [2012]
A double-blinded randomized controlled trial of laparoendoscopic single-site
access versus conventional 3-port appendectomy. [2012]
Behavioral intervention as an add-on therapy in epilepsy: designing a clinical
trial. [2012]
Dexamethasone and long-term survival in bacterial meningitis. [2012]
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic
therapy in cystic fibrosis. [2012]
Blood pressure lowering efficacy of potassium-sparing diuretics (that block the
epithelial sodium channel) for primary hypertension. [2012]
Vitamin E for Alzheimer's dementia and mild cognitive impairment. [2012]
Multivitamin supplementation in HIV infected adults initiating antiretroviral
therapy in Uganda: the protocol for a randomized double blinded placebo
controlled efficacy trial. [2012]
Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in
patients receiving botulinum toxin therapy. [2012]
Reduction in intraoperative bacterial contamination of peripheral intravenous
tubing through the use of a passive catheter care system. [2012]
Effect of abiraterone acetate and prednisone compared with placebo and prednisone
on pain control and skeletal-related events in patients with metastatic
castration-resistant prostate cancer: exploratory analysis of data from the
COU-AA-301 randomised trial. [2012]
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein
convertase subtilisin/kexin type 9 in combination with a statin in patients with
hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled,
dose-ranging, phase 2 study. [2012]
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein
convertase subtilisin/kexin type 9 as monotherapy in patients with
hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled,
phase 2 study. [2012]
Instant dentin hypersensitivity relief of a single topical application of an
in-office desensitizing paste containing 8% arginine and calcium carbonate: A
split-mouth, randomized-controlled study. [2012]
The study of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE):
design and rationale. [2012]
The paroxetine 352 bipolar trial: A study in medical ghostwriting. [2012]
Multiple micronutrient supplementation in Tanzanian infants born to HIV-infected
mothers: a randomized, double-blind, placebo-controlled clinical trial. [2012]
Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol
levels in statin-intolerant patients: the GAUSS randomized trial. [2012]
Atorvastatin with or without an antibody to PCSK9 in primary
hypercholesterolemia. [2012]
|
